Italian Association of Clinical Endocrinologists (AME) and Italian AACE Chapter Position Statement for Clinical Practice: Acromegaly - Part 1: Diagnostic and Clinical Issues
- PMID: 31985386
- PMCID: PMC7579251
- DOI: 10.2174/1871530320666200127103320
Italian Association of Clinical Endocrinologists (AME) and Italian AACE Chapter Position Statement for Clinical Practice: Acromegaly - Part 1: Diagnostic and Clinical Issues
Abstract
Acromegaly is a rare disease. Improvements in lifespan in these patients have recently been reported due to transsphenoidal surgery (TSS), advances in medical therapy, and strict criteria for defining disease remission. This document reports the opinions of a group of Italian experts who have gathered together their prolonged clinical experience in the diagnostic and therapeutic challenges of acromegaly patients. Both GH and IGF-I (only IGF-I in those treated with Pegvisomant) are needed in the diagnosis and follow-up. Comorbidities (cardio-cerebrovascular disease, sleep apnea, metabolic derangement, neoplasms, and bone/joint disease) should be specifically addressed. Any newly diagnosed patient should be referred to a multidisciplinary team experienced in the treatment of pituitary adenomas.
Keywords: Acromegaly; GH; IGF-I; comorbidities; discrepant; pituitary.
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.
References
-
- Cozzi R., Baldelli R., Colao A., Lasio G., Zini M., Attanasio R., Chanson P., Giustina A., Ghigo E., Strasburger C. Italian Association of Clinical Endocrinologists (AME). AME Position Statement on clinical management of acromegaly. J. Endocrinol. Invest. 2009;32(Suppl. 6):2–25. - PubMed
-
- Atkins D., Best D., Briss P.A., Eccles M., Falck-Ytter Y., Flottorp S., Guyatt G.H., Harbour R.T., Haugh M.C., Henry D., Hill S., Jaeschke R., Leng G., Liberati A., Magrini N., Mason J., Middleton P., Mrukowicz J., O’Connell D., Oxman A.D., Phillips B., Schünemann H.J., Edejer T., Varonen H., Vist G.E., Williams J.W., Jr, Zaza S., GRADE Working Group Grading quality of evidence and strength of recommendations. BMJ. 2004;328(7454):1490–1497. doi: 10.1136/bmj.328.7454.1490. - DOI - PMC - PubMed
-
- Swiglo B.A., Murad M.H., Schünemann H.J., Kunz R., Vigersky R.A., Guyatt G.H., Montori V.M. A case for clarity, consistency, and helpfulness: state-of-the-art clinical practice guidelines in endocrinology using the grading of recommendations, assessment, development, and evaluation system. J. Clin. Endocrinol. Metab. 2008;93(3):666–673. doi: 10.1210/jc.2007-1907. - DOI - PubMed
-
- Guyatt G.H., Oxman A.D., Vist G.E., Kunz R., Falck-Ytter Y., Alonso-Coello P., Schünemann H.J., GRADE Working Group GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336(7650):924–926. doi: 10.1136/bmj.39489.470347.AD. - DOI - PMC - PubMed
-
- Fernandez A., Karavitaki N., Wass J.A. 2010.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous